Back to Search
CHRISTOPHER UNGER, DMD
DMD
General Practice Dentistry
NPI: 1669996930Individual
Specialties, Licenses & Credentials
Dentist
Dentist
Code: 122300000X
D13903(MN)
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
D13903(MN)36835(TX)062381(NY)
Research & Publications (20)
Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin.
PMID 17699865·Clin Cancer Res·2007
3-trial
Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.
PMID 11367875·Arzneimittelforschung·2001
3-trial
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.
PMID 19404684·Support Care Cancer·2010
3-trial
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.
PMID 19148580·Invest New Drugs·2010
4-observational
An in vitro ES cell imprinting model shows that imprinted expression of the Igf2r gene arises from an allele-specific expression bias.
PMID 19141673·Development·2009
7-preclinical
Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression.
PMID 18932205·J Cell Physiol·2009
8-other
Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
PMID 19399788·Prostate·2009
7-preclinical
Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.
PMID 19556288·Hum Reprod·2009
7-preclinical
Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer.
PMID 19142174·Pancreas·2009
7-preclinical
Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
PMID 18164554·Neuroscience·2008
7-preclinical
Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor.
PMID 18716037·Hum Reprod·2008
8-other
Good manufacturing practice and clinical-grade human embryonic stem cell lines.
PMID 18632697·Hum Mol Genet·2008
6-review
A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.
PMID 17554540·Cancer Chemother Pharmacol·2008
7-preclinical
Derivation of human skin fibroblast lines for feeder cells of human embryonic stem cells.
PMID 18770630·Curr Protoc Stem Cell Biol·2008
8-other
Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
PMID 18617691·Stem Cells·2008
7-preclinical
Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
PMID 17973264·Int J Cancer·2008
7-preclinical
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.
PMID 18063875·Onkologie·2007
3-trial
OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h.
PMID 17898799·Gene Ther·2007
7-preclinical
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors.
PMID 17634482·J Clin Oncol·2007
3-trial
Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
PMID 17623088·Lipids Health Dis·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 900 LARK DR
ALBANY, NY 12207 - Phone
- (518) 465-6330
Quick Facts
- NPI
- 1669996930
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile